CLINICAL_TRIALS
trial_result
· 2014-11-20
Clinical Trial Update: Clinical Trial of Consolidation Treatment With Iodine I 131 Tositumomab for Multiple Myeloma [Phase 2]
Summary
A Phase 2 trial evaluating consolidation treatment with iodine-131 labeled tositumomab for multiple myeloma has completed and posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University of Michigan Rogel Cancer Center | Conditions: Multiple Myeloma | Phase 2 | Status: COMPLETED | Results posted: 2014-11-20